Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
06/2009
06/03/2009EP1165553B1 C10 ester substituted taxanes as antitumor agents
06/03/2009CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
06/03/2009CN101445463A Beta2-adrenergic receptor agonists
05/2009
05/27/2009CN100491362C Biologically active methylene blue derivatives
05/27/2009CN100491316C Novel compounds, their preparation and use
05/26/2009CA2439671C Aquatic animal treatment method and composition containing pimenta extract
05/20/2009CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101434573A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101434572A Prodrugs of GABA analogs, compositions and uses thereof
05/20/2009CN100488505C Use of Darifenacin and its salts
05/19/2009CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them
05/14/2009US20090124605 Pyrazolo-Quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors
05/14/2009US20090124540 Anti-adhesion composites and methods of use thereof
05/13/2009EP1320540B1 Peptidomimetic protease inhibitors
05/13/2009CN100486642C 疫苗 Vaccine
05/12/2009US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
05/12/2009US7531528 mixture of aqueous carrier liquid containing dissolved glucocorticoid and 3-oxoandrostane carbothioic coompound
05/12/2009CA2475302C Controlled synthesis of ziprasidone and compositions thereof
05/12/2009CA2361402C Bis-sulfonamides
05/07/2009US20090118160 Heterocyclic compounds and methods of use
05/06/2009EP1343782B1 Pyrimidineamines as angiogenesis modulators
05/06/2009CN101423493A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same
05/06/2009CN101423492A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same
05/05/2009CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
04/2009
04/29/2009EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease
04/29/2009CN100482646C Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
04/22/2009EP2050453A1 Pharmaceutical combinations of meloxicam, tramadol and paracetamol
04/21/2009US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors
04/08/2009EP2045267A2 Humanized antibodies that recognize beta amyloid peptide
04/08/2009EP2044941A1 Multiple-phase formulation of drospirenone and estradiol as a contraceptive
04/08/2009EP1448566B3 Chemokine receptor antagonists and methods of use thereof
04/07/2009US7514456 Nicotinamide derivatives useful as p38 inhibitors
04/07/2009CA2362833C Phenylalaninol derivatives
04/02/2009US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof
04/01/2009EP1620429B1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
03/2009
03/31/2009CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
03/31/2009CA2349268C A process for the preparation of suspensions of drug particles for inhalation delivery
03/24/2009US7507744 Spiroazabicyclic heterocyclic compounds
03/18/2009EP2036549A1 Novel Composition
03/18/2009EP1386912B1 Cyclic amidine derivative
03/17/2009US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use
03/11/2009CN101381339A Prodrugs of gaba analogs, compositions and uses thereof
03/05/2009US20090062362 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System
02/2009
02/25/2009EP1474117B1 Composition for inhalation
02/24/2009CA2356151C Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
02/12/2009US20090042911 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
02/11/2009CN101362731A Heterocyclic compounds and methods of use
02/11/2009CN100460412C Process for preparing amine platinum complexes
02/10/2009CA2458067C Use of flibanserin in the treatment of sexual disorders
02/05/2009US20090036682 Crystalline form of 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; used in the treatment of CNS and other disorders
02/04/2009CN101357915A Diazabicyclic central nervous system active agents
02/04/2009CN100457757C Novel spiro compounds
02/04/2009CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
02/04/2009CN100457738C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives
02/03/2009CA2341397C Immediate release tablet
01/2009
01/27/2009US7482354 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
01/22/2009US20090023760 anticarcinogenic agent; thymidylate synthase (TS) inhibitors; Tri-tert-butyl N-{N-{4-[N-((6RS)-2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamate
01/21/2009CN101347431A Use of flibanserin in the treatment of sexual disorders
01/15/2009US20090018193 Essential fatty acids in the prevention of cardiovascular events
01/14/2009EP2014298A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
01/14/2009EP2014285A1 NPYY5 antagonists
01/14/2009EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it
01/14/2009EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
01/14/2009CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
01/13/2009US7476688 Cyclic amidine derivatives
01/07/2009CN100448893C Humanized antibodies that recognize beta amyloid peptide
12/2008
12/31/2008EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/31/2008CN100446811C Composition comprising immunogenic microparticles
12/30/2008CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
12/30/2008CA2391293C .beta.2-adrenergic receptor agonists
12/24/2008CN101327326A Vaginally administered anti-dysrhythmic agents for treating pelvic pain and infertility
12/23/2008CA2386627C Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
12/18/2008US20080312219 Biologically active methylene blue derivatives
12/18/2008US20080311156 Vaccines
12/17/2008EP1614426B1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
12/16/2008US7465462 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
12/16/2008US7465445 Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM
12/10/2008EP1252893B1 Medicine containing anemonin as effective component for treating aseptic inflammation
12/09/2008US7462643 Essential fatty acids in the prevention of cardiovascular events
12/03/2008EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol
11/2008
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/25/2008US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract
11/25/2008CA2370565C Dermally applicable vitamin d-containing pharmaceutical compositions
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/19/2008EP1358213B1 Humanized antibodies that recognize beta amyloid peptide
11/19/2008CN101305990A Use of EDG receptor binding agents in cancer
11/18/2008US7452888 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders
11/18/2008US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
11/18/2008CA2516557C Triazole compounds useful in therapy
11/12/2008CN101302204A Quinazolone compound, composition and application including the same
11/12/2008CN101302180A 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
11/12/2008CN101301475A Peg化因子vii糖型 Peg factor vii sugar type
11/12/2008CN100432103C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells.
11/11/2008US7449487 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1
11/06/2008US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
11/05/2008EP1200424B1 C7 heterosubstituted acetate taxanes as antitumor agents
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 32